Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by influencing key signaling pathways. This finding points to MICAL2 as a potential target for novel treatments aimed at improving survival rates in patients suffering from this aggressive cancer. Discovery of MICAL2’s Role…